NCT00481364View on ClinicalTrials.gov

Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

446

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Vascular CalcificationAtherosclerosisDyslipidemiaInflammation

Interventions

DRUG

atorvastatin

atorvastatin 40 mg/day

DRUG

placebo

1 tb/day

Trial Locations (1)

35100

Ege University School of Medicine, Division of Nephrology, Bornova

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Ercan OK

OTHER